Abstract
Introduction Adherence is often cited as an important metric to demonstrate sustained engagement of an individual or population with a health technology, but its definition is often ill-defined. Any adherence definition made for digital health interventions must be clearly defined to ensure a consistent approach to measuring sustained use as an indicator of impact.
Methods This study followed mathematically-defined definitions of distinct aspects of adherence: initial adoption, consistency, duration, and dropout. These were then applied to a digital physiotherapy dataset of older adults (N=56). Participants were assigned 3 sessions a week of exergames (exercise-based videogames) for 12 weeks using MIRA rehab software platform.
Results The following adherence characteristics emerged: an initial dropout of 3% (completed ≤3 sessions), 20% of participants achieving the desired consistency (≥3 sessions a week for 12 weeks), 39% of participants passing a duration threshold (completing ≥20 minutes a week for 12 weeks), and an average dropout at 72.3% (when judged by percentage of sessions completed at dropout).
Conclusion The approach used for measuring and reporting adherence metrics allows readers to draw clear conclusions about the different aspects of engagement that users displayed with the digital health programme. This type of reporting is recommended for all future digital health studies reporting adherence measures to ensure a consistent approach to reporting and comparing digital health interventions and their impact.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT02634736
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics approvals for this study were obtained from London - Camden & Kings Cross Research Ethics Committee, reference number 16/LO/0200.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Data Availability
Data are available from the University of Manchester Institutional Data Access (contact via corresponding author Dr Emma Stanmore) for researchers who meet the criteria for access to confidential data.
